Ads
related to: keytruda cancer drug- Contact Us
Have Questions? Don’t Hesitate.
Contact Us Today.
- Precision Oncology
Finding Cancer's Fingerprint.
Learn More.
- NRG1 Fusion
More Aggressive Than You Think.
Learn About NGR1 Today.
- Genomic Landscape
Genomics are Changing the Future
of Oncology. Learn More.
- Contact Us
Search results
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 23 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 22 hours agoThe decision follows a US Food and Drug Administration (FDA) approval for the Opdivo combination...
Merck Nears $1.3 Billion Cash Deal for Eye-Drug Company EyeBio, WSJ Reports
US News & World Report· 1 day agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 7 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Reuters via Yahoo Finance· 1 day agoMerck has said it's in the market for deals of up to around $15 billion as it plans ways to deal...
Merck to pay as much as $3 billion for eye treatment startup
Crain's New York Business· 22 hours agoWhile it raised its profit and sales forecast for the year on Keytruda sales, Merck has been on the...
Merck to acquire eye drug company EyeBio for up to $3 billion
WHTC 1450 Holland· 1 day ago(Reuters) - Merck said on Wednesday it would acquire eye diseasedrug developer EyeBio for up to $3...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 6 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoTILT-123 is an oncolytic adenovirus featuring tumour necrosis factor alpha (TNFα) and interleukin-2...
Ads
related to: keytruda cancer drug